Your browser doesn't support javascript.
loading
[Kinetics of SARS-CoV-2-specific antibodies among inactivated COVID-19 vaccine recipients, SARS-CoV-2 natural infection cases, and breakthrough cases].
Jin, L R; Li, C C; Chen, C; Wang, Y; Wang, Y; He, M; Ding, S N; Wei, M W; Tian, H; Kong, X X; Dong, C; Zhou, L; Peng, J F; Wang, Z G; Zhu, F C; Zhu, L G.
  • Jin LR; School of Public Health, Southeast University, Nanjing 210009, China.
  • Li CC; Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Chen C; Institute of Acute Infectious Disease Control, Changzhou Municipal Center for Disease Control and Prevention, Changzhou 213000, China.
  • Wang Y; Institute of Acute Infectious Disease Control, Yangzhou Municipal Center for Disease Control and Prevention, Yangzhou 225000, China.
  • Wang Y; Laboratory Department, Yangzhou Municipal Center for Disease Control and Prevention, Yangzhou 225000, China.
  • He M; Laboratory Department, Nanjing Municipal Center for Disease Control and Prevention, Nanjing 210003, China.
  • Ding SN; Institute of Acute Infectious Disease Control, Nanjing Municipal Center for Disease Control and Prevention, Nanjing 210003, China.
  • Wei MW; Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Tian H; Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Kong XX; Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Dong C; Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Zhou L; Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Peng JF; Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Wang ZG; Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Zhu FC; Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
  • Zhu LG; School of Public Health, Southeast University, Nanjing 210009, China Institute of Acute Infectious Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 56(12): 1834-1837, 2022 Dec 06.
Article en Zh | MEDLINE | ID: mdl-36536574
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: Zh Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: Zh Año: 2022 Tipo del documento: Article